Draft:SoftMining

SoftMining is a startup focusing on the integration of Artificial Intelligence (AI), drug discovery, and eHealth. The company is known for its commitment to innovative approaches and its history of achievements in the healthcare and technology sectors. TEST

Overview
Based in Salerno, Italy, SoftMining has gained attention for its work in the areas of AI-based drug discovery and eHealth solutions. The company's contributions have led to its recognition on the global stage.

Notable Achivements

 * 1) Best Startup in Italy 2023: SoftMining was  recognized as one of the top 15 startup in Italy in 2023, showcasing its significant impact on the Italian startup ecosystem..
 * 2) AI Solutions for Sustainability 2021: in 2021, SoftMining was featured among the 100 best AI solutions for sustainability, highlighting its commitment to driving positive change.
 * 3) COVID-19 Pandemic Response: During the COVID-19 pandemic, SoftMining played a crucial role by developing the first European app for contact tracing . With the endorsement of Regione Campania, this centralized app was utilized by more than 120.000 volunteers, contributing to the fight against the pandemic

Core activities
SoftMining primarily operates in the following core areas:


 * Drug Discovery: The company is at the forefront of AI-driven drug discovery, leveraging cutting-edge technologies to identify novel therapeutic compounds.
 * eHealth Solutions: SoftMining is dedicated to creating innovative eHealth solutions that enhance patient care and healthcare delivery.

Drug Development Program
Since 2020, SoftMining has initiated its drug development programs. These programs are based on repositioned compounds and focus on addressing critical healthcare needs, particularly in the realm of cancer diseases. Notable projects include:


 * NEWROAD : a significant undertaking aimed at developing repositioned compounds for cancer treatment.
 * MIND: an innovative project focusing on exploring new avenues in cancer disease management.

SoftMining's focus on drug development represents a significant effort in the pursuit of enhancing patient outcomes and advancing global healthcare.